TJP2 Gene Mutation c.G1012A May Responsible for Congenital Hearing Loss with Incomplete Penetrance in An Iranian Pedigree

Document Type: Case-study


1 Department of Clinical Biochemistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Biochemistry Department, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran

4 Department of Otorhinolaryngology, Loghman Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran



Hereditary hearing loss (HHL) comprises half of the congenital deafness which arises from genetic mutations. Mutations in the TJP2 gene, encoding tight junction protein 2, are one of the gene alterations in HHL resulting in an autosomal dominant nonsyndromic form of the disease. An 11-year-old male patient with clinically approved congenital hearing loss was referred to our laboratory. The molecular genetic analysis detected an atypical heterozygous variant -c.1012G > C, p.G338R in exon 5 of the TJP2 gene on chromosome 9 position 71836379 (GRch37). Segregation analysis for his parents has uncovered the same mutation in the patient’s mother, but without any deafness phenotype. This case report provided evidence to demonstrate for the first time the incomplete penetrance of this TJP2 mutation and proposed this mutation as a “likely pathogenic” variant in an Iranian pedigree.


Baux D, Vaché C, Blanchet C, Willems M, Baudoin C, Moclyn M, et al. 2017. Combined genetic approaches yield a 48% diagnostic rate in a large cohort of French hearing-impaired patients. Sci Rep 7(1): 16783.

Cohn AC, Toomes C, Potter C, Towns KV, Hewitt AW, Inglehearn CF, et al. 2007. Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations. Am J Ophthalmol 143(4): 656-662.

Egilmez OK, Kalcioglu MT. 2016 Genetics of nonsyndromic congenital hearing loss. Scientifica (Cairo) 2016:7576064.

Ghasemnejad T, Shekari Khaniani M, Zarei F, Farbodnia M, Mansoori Derakhshan S. 2017. An update of common autosomal recessive non-syndromic hearing loss genes in Iranian population. Int J Pediatr Otorhinolaryngol 97:113-126.

Horimoto AR, Onodera MT, Otto PA. 2010 PENCALC: a program for penetrance estimation in autosomal dominant diseases. Genet Mol Biol 33(3) 455-459.

King CR, Stansfield DW, Pamela MK. 2007. A dictionary of genetics. New York: Oxford University Press.

Koohiyan M, Azadegan-Dehkordi F, Koohian F, Abolhasani M, Hashemzadeh-Chaleshtori M. 2019. Genetics of hereditary hearing loss in east Iran population: a systematic review of GJB2 mutations. Intractable Rare Dis Res 8(3):172-178.

Koohiyan M, Azadegan-Dehkordi F, Koohian F, Hashemzadeh-Chaleshtori M. 2019. Genetics of hearing loss in north Iran population: an update of spectrum and frequency of GJB2 mutations. J Audiol Otol 23(4):175-180.

Kremer H. 2019. Hereditary hearing loss; about the known and the unknown. Hear Res 376: 58-68.

Lenz DR, Avraham KB. 2011. Hereditary hearing loss: from human mutation to mechanism. Hear Res 281: 3-10.

Marschark M, Spencer PP. 2003. Hearing and speech perception. In:  Oxford Handbook of Deaf Studies, Language, and Education. Oxford University Press, USA.

Op de Beeck K, Schacht J, Van Camp G. 2011. Apoptosis in acquired and genetic hearing impairment: the programmed death of the hair cell. Hear Res 281: 18-27.

Otto PA, Horimoto AR. 2012. Penetrance rate estimation in autosomal dominant conditions. Genet Mol Biol 35(3): 583-588.

Pollak A et al. 2007. M34T and V37I mutations in GJB2 associated hearing impairment: evidence for pathogenicity and reduced penetrance. Am J Med Genet A 143:2534-43.

Shearer AE, Hildebrand MS, Smith RJ. 2017. Hereditary hearing loss and deafness overview. In:  GeneReviews®[Internet]. University of Washington, Seattle,

Thiselton DL, Alexander C, Taanman JW, Brooks S, Rosenberg T, Eiberg H, et al. 2002. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy. Invest Ophthalmol Vis Sci 43(6):1715-24.

Vona B, Müller T, Nanda I, Neuner C, Hofrichter MA, Schröder J, et al. 2014. Targeted next-generation sequencing of deafness genes in hearing-impaired individuals uncovers informative mutations. Genet Med 16: 945-53.

Walsh T, Pierce SB, Lenz DR, Brownstein Z, Dagan-Rosenfeld O, Shahin H, et al. 2010. Genomic duplication and overexpression of TJP2/ZO-2 leads to altered expression of apoptosis genes in progressive nonsyndromic hearing loss DFNA51. Am J Hum Genet 87: 101–109.

Wang HY, Zhao YL, Liu Q, Yuan H, Gao Y, Lan L, et al. 2015. Identification of two disease-causing genes TJP2 and GJB2 in a Chinese family with unconditional autosomal dominant nonsyndromic hereditary hearing impairment. Chin Med J 128: 3345-51.

Wasano K, Matsunaga T, Ogawa K, Kunishima S. 2016. Late onset and high-frequency dominant hearing loss in a family with MYH9 disorder. Eur Arch Otorhinolaryngol 273: 3547-3552.

Xu J, Kausalya PJ, Phua DC, Ali SM, Hossain Z, Hunziker W. 2008. Early embryonic lethality of mice lacking ZO-2, but Not ZO-3, reveals critical and nonredundant roles for individual zonula occludens proteins in mammalian development. Mol Cell Biol 28: 1669-78.

Yang T, Guo L, Wang L, Yu X. 2019. Diagnosis, intervention, and prevention of genetic hearing loss. Adv Exp Med Biol 1130: 73-92.

Zlotogora J. 2003. Penetrance and expressivity in the molecular age. Genet Med 5: 347-52.

Zou S, Mei X, Yang W, Zhu R, Yang T, Hu H. 2019. Whole-exome sequencing identifies rare pathogenic and candidate variants in sporadic Chinese Han deaf patients. Clin Genet doi: 10.1111/cge.13638.